Table 2. Subject characteristics in relation to MetS prevalence or not.
| Metabolic syndrome | |||
|---|---|---|---|
| No (n = 726) | Yes (n = 204) | Difference p-value** | |
| Per cent women | 52.1% | 52.5% | n.s. |
| Median age (yrs.) | 52.7 (53.6–61.4) | 58.6 (54.7–62.5) | 0.005 |
| University degree level(%) | 41.3 | 27.6 | 0.001 |
| Regular smokers (%) | 11.6 | 13.9 | n.s. |
| High stress (%) * | 20.3 | 24.1 | n.s. |
| SED (% of wear time) | 60.2 (54.4–65.8) | 62.5 (55.5–68.8) | 0.001 |
| LIPA (% of wear time) | 35.4 (30.4–41.1) | 34.3 (28.3–40.9) | 0.09 |
| MVPA (% of wear time) | 4.1 (2.7–5.8) | 2.8 (1.7–4.7) | <0.001 |
| TPA (cpm) | 345 (277–433) | 288 (227–376) | <0.001 |
| Est. VO 2 max (ml x min -1 x kg -1 ) | 35.5 (28.0–40.4) | 32.3 (27.4–37.3) | 0.002 |
Data are presented as median (Q1-Q3) or as per cent, where applicable. Differences between MetS-strata were analysed using Mann-Whitney U-test or chi-square test.
*Reporting tension, anxiousness, nervousness or sleep disturbances more or less constantly over the last year or longer
** Chi-square test for nominal data and Mann-Whitney test for ordinal data.